Scanning for cancer genomic changes in plasma: toward an era of personalized blood-based tumor markers.

Abstract

The analysis of circulating cell-free tumor DNA has remarkable potential for the detection and monitoring of cancers. Genetic alterations are present in virtually all types of cancers, allowing broad applicability of this approach regardless of the primary organ and histologic type of the cancer. To date only a few specific proteins and glycoproteins have… (More)
DOI: 10.1373/clinchem.2013.207381

Topics

Cite this paper

@article{Chan2013ScanningFC, title={Scanning for cancer genomic changes in plasma: toward an era of personalized blood-based tumor markers.}, author={K. C. Allen Chan}, journal={Clinical chemistry}, year={2013}, volume={59 11}, pages={1553-5} }